Bioline Rx reported $2.62B in Ordinary Share Capital for its fiscal quarter ending in June of 2026.





Ordinary Share Capital Change Date
Arca Biopharma USD 50.17M 1.45M Mar/2026
Bio Path USD 9.34M 100K Mar/2026
Bioline Rx USD 2.62B 10.16M Jun/2026
Capricor Therapeutics USD 57.37M 11.65M Dec/2025